Cabenuva, and it comes from the pharmaceutical company, Viiv Healthcare, which is owned by GlaxoSmithKline.Cabenuva consists of two injections: rilpivirine, commonly sold as Edurant by Janssen, and a new drug, cabotegravir, from ViiV Healthcare.
They’re administered as intramuscular injections in your buttocks.The FDA granted its approval last Thursday (January 21).ViiV has also developed a pill form of cabotegravir.